{"transactions":[{"id":1567661,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2024-03-19T19:29:06.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":35000,"value":1225000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person acquired a convertible note, face value $35,000.  The note is convertible into shares of the Issuer's common stock at a price of $0.01 per share."}],"balance_after":4500000,"derivative":{"exercise_price":0.01,"exercise_date":"2024-03-15","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3500000},"source":{"system":"sec-edgar","filing":"0001096906-24-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690624000517/form4.xml","form_type":"4"}},{"id":2151780,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:25:05.000Z","date":"2022-09-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired an option to purchase up to 1,000,000 shares of common stock. 50% of the shares may be purchased immediately and the remaining 50% of the shares may purchased at the date which is six (6) months following the grant date."}],"balance_after":1500000,"derivative":{"exercise_price":0.052,"expiration_date":"2032-08-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001096906-22-002333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002333/form4.xml","form_type":"4"}},{"id":2151779,"issuer":{"id":9689,"kind":"organization","name":"AXIM BIOTECHNOLOGIES, INC."},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2022-09-23T16:22:13.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reporting Person acquired the option to purchase 500,000 shares of Issuer's common stock (\"Option Shares\") on May 13, 2020 (the \"Date of Grant\").  One-third of the Option Shares will vest on the Date of Grant; (iii) one-third of the Option Shares will vest six (6) months from the Date of Grant; and (iv) the remaining one-third of Option Shares shall vest twelve (12) Months from the Date of Grant, provided, however, that there has not been a Termination of Service as of such date.  In no event shall the Option become exercisable for any additional Option Shares after a Termination of Service."}],"balance_after":500000,"derivative":{"exercise_price":0.0126,"expiration_date":"2030-03-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001096906-22-002332","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690622002332/form4.xml","form_type":"4"}},{"id":2785429,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-03-16T16:59:54.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months thereafter."}],"balance_after":600000,"derivative":{"exercise_price":0.13,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001607062-21-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000160706221000053/primary_doc.xml","form_type":"4"}},{"id":3159122,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-06T21:48:11.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the option shares vest on the date of grant and the remaining option shares vest in equal monthly installments over 36 months commencing with the\nvesting commencement date of January 1, 2020."}],"balance_after":300000,"derivative":{"exercise_price":0.57,"expiration_date":"2030-05-03","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001683168-20-001433","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000168316820001433/ownership.xml","form_type":"4"}},{"id":3159121,"issuer":{"id":126275,"kind":"organization","name":"NEUROPATHIX, INC.","symbol":"NPTX"},"owners":[{"id":92867,"kind":"person","name":"Scott Timothy Richard","position":1,"cik":"0001709014","reported_name":"Scott Timothy Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T21:45:53.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":250000,"price":0.1,"value":25000.0,"ownership":{"direct":true},"balance_after":250000,"source":{"system":"sec-edgar","filing":"0001683168-20-001430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615999/000168316820001430/ownership.xml","form_type":"4"}}]}